CN214857300U - Novel uterine cavity hemostasis, adhesion prevention and liquid circulation compounding device - Google Patents
Novel uterine cavity hemostasis, adhesion prevention and liquid circulation compounding device Download PDFInfo
- Publication number
- CN214857300U CN214857300U CN202120359574.3U CN202120359574U CN214857300U CN 214857300 U CN214857300 U CN 214857300U CN 202120359574 U CN202120359574 U CN 202120359574U CN 214857300 U CN214857300 U CN 214857300U
- Authority
- CN
- China
- Prior art keywords
- liquid
- triangular
- balloon
- tube
- uterus oviduct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Surgical Instruments (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
The utility model relates to the technical field of medical instruments, and discloses a novel uterine cavity hemostasis, anti-adhesion and liquid-flowing composite device, which comprises a triangular balloon, a uterine tube liquid-flowing tube, a metal operating rod and an outer sleeve; the triangular balloon is made of an elastic silica gel material; the surface of the triangular balloon is provided with a plurality of convex fine particles; the triangular balloon is hollow and is in an inverted triangle shape; the bottom of the triangular balloon is provided with an opening; the uterus oviduct liquid-passing tube is an inverted Y-shaped tube body; the head end of the uterus oviduct liquid-passing tube can be tightly connected with the opening of the triangular saccule; the tail end of the uterus oviduct liquid-passing tube is respectively provided with a balloon fixing port and a liquid-passing port; the metal operating rod can penetrate through the liquid passing port and penetrate to the head end of the uterus oviduct liquid passing tube; the openings at the two ends of the outer sleeve enable the triangular saccule to penetrate through the inside and the outside of the outer sleeve. The utility model discloses effectively prevent glutinous even, stanch, convenient dismantlement can lead to liquid, avoids infecting.
Description
Technical Field
The utility model relates to the technical field of medical equipment, more specifically relates to a novel palace chamber stanchs, antiseized even, leads to liquid set composite.
Background
The uterine adhesion (IUA) is caused by various factors such as surgical wounds, infection and the like, means that the basal layer of endometrium is damaged, muscle layer tissues are exposed, and the mutual adhesion of uterine wall tissues is caused, and is a common complication after artificial abortion operation and uterine curettage operation. At present, various auxiliary methods at home and abroad are used for preventing postoperative re-adhesion, including placing intrauterine devices (IUDs), Foley catheters, sodium hyaluronate, amnion transplantation, hormone replacement treatment and the like, but the most ideal prevention method is not available.
The human amniotic membrane can promote the growth and development of intimal cells and inhibit inflammatory reaction, the treated fresh amniotic membrane is covered on the surface of the Foley balloon catheter, the amniotic membrane effectively promotes the regeneration of endometrium, the balloon plays a supporting function, and the amniotic membrane and the balloon are combined for prevention, so that discomfort of a patient is reduced, the biological barrier effect of the patient can be realized, and the method is a new mode for treating IUA at present. As early as the sixties of the twentieth century, foreign scholars advocated using an intrauterine device (IUD) for prevention of adhesion after a hysteroscopic uterine adhesion separation operation (TCRA), as a conventional method for prevention of re-adhesion after TCRA operation, there was a controversy on the effect that the severe IUA wound surface could not be effectively isolated due to its limited surface area and volume.
Foley balloons since the 20 th 30 th century Frederick Foley invented self-anchoring balloons with catheters, in recent years Foley balloons have taken an important role in preventing recurrence of adhesions after TCRA. Foley catheter can restore uterine cavity anatomy and improve menstruation more effectively, but because of its spherical structure, it cannot be completely attached to the four walls of uterine cavity, especially the bilateral uterine horns, and can cause local overpressure and ischemic injury of endometrium, which is not good for endometrial repair. Compared with a Foley balloon, the Cook balloon can better fit the inner wall of a uterine cavity by virtue of the inverted triangular shape, can uniformly bear force on each wall of the cavity and uterine corners at two sides, reduces necrosis caused by over compression of an inner membrane, can play a role in compression hemostasis and supporting a physical barrier when being full, and can also support the edge of the uterine cavity which is most prone to peripheral uterine cavity adhesion, so that the inner membrane at the edge of the uterine cavity grows along the surface of the balloon, and a better anti-adhesion effect is achieved. Myers et al found that the triangular Cook balloon pressed the uterine wall less than the Foley balloon, thereby reducing tissue ischemic necrosis caused by balloon insertion and enabling the endometrium to be repaired and regenerated. Unfortunately, the Cook balloon also has the problems that the tail tube is too long and is kept in the vagina for a long time, and the germs are retrograde to cause infection and the like in the application process of the Cook balloon as well as the Foley balloon. Therefore, a medical device is urgently needed, which can effectively prevent the sacculus from falling off and vaginal bleeding and avoid infection in clinical work, so that the time for the sacculus to stay in the uterine cavity is longer, and the recurrence rate of intrauterine adhesion after TCRA is lower.
SUMMERY OF THE UTILITY MODEL
An object of the utility model is to provide a can be in clinical work the utility model discloses effective prevention is glutinous even, stanchs, and convenient the dismantlement can lead to liquid, avoids infecting. The novel uterine cavity hemostasis, adhesion prevention and liquid circulation composite device has the advantages that the balloon can be kept in the uterine cavity for a longer time, and the recurrence rate of uterine cavity adhesion after TCRA is lower.
In order to solve the problems, the novel uterine cavity hemostasis, adhesion prevention and liquid flowing composite device comprises a triangular balloon, a uterine tube liquid flowing tube, a metal operating rod and an outer sleeve; the triangular balloon is made of an elastic silica gel material; the surface of the triangular balloon is provided with a plurality of convex fine particles; the triangular balloon is hollow and is in an inverted triangle shape; the bottom of the triangular balloon is provided with an opening; the uterus oviduct liquid-passing tube is an inverted Y-shaped tube body; the head end of the uterus oviduct liquid-passing tube can be tightly connected with the opening of the triangular saccule; the tail end of the uterus oviduct liquid-passing tube is respectively provided with a balloon fixing port and a liquid-passing port; the tail end liquid through port can penetrate through the metal operating rod and penetrate to the head end of the liquid through pipe; the openings at the two ends of the outer sleeve enable the triangular saccule to penetrate through the inside and the outside of the outer sleeve.
Particularly, the inner diameter of the opening of the triangular balloon is 3 mm; the uterus oviduct liquid-passing tube adopts a 6Fr uterus oviduct liquid-passing tube (the diameter is 3 mm), and can be tightly connected with the saccule.
In particular, the metal operating rod comprises an operating head and a long rod; the operating head is fixedly connected with a long rod; the diameter of the long rod is 2 mm.
Specifically, the diameter of the convex fine particles is 0.3 mm.
Particularly, the triangular saccule is made of medical silica gel.
In particular, scales are arranged on the uterus oviduct liquid-passing tube.
The utility model has the advantages that:
1. the utility model discloses not only have the appearance of falling the triangle, can laminate palace intracavity wall better, not only can play oppression hemostasis when full, still can possess bigger bearing surface area and volume, the reducible traditional sacculus of the tiny particle on triangle-shaped sacculus surface leads to hindering the prosthetic shortcoming of regeneration of endometrium because of the blood supply of oppression uterine wall. The detachable uterus oviduct liquid passing tube is designed to be provided with a triangular balloon, so that the fixing function is realized, and the hollow liquid passing tube can be used for the liquid passing of the oviduct. The triangular balloon is completely arranged in the uterine cavity, is similar to an inert intrauterine device, effectively avoids the defect that the tail tube of the traditional hook balloon is exposed to cause infection, can be kept in the uterine cavity for a longer time, has better adhesion recurrence prevention effect, and can improve the receptivity of endometrium, thereby improving the pregnancy rate and the survival rate.
2. The utility model discloses need not just can place into the palace chamber with cervix uteri expansion stick to No. 10 with traditional COOK sacculus, only need tractive uterus oviduct liquid tube gently and can reach the purpose of triangle-shaped sacculus and separation of uterus oviduct liquid tube, do not need extra cutting off clinically, and its easy operation easily learns, and its price is compared cheaper with domestic and foreign like product moreover, and more economical and applicable, changes in dismantlement, operation.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to these drawings without creative efforts.
FIG. 1 is a diagram of a triangular balloon and a uterotubal catheter according to an embodiment of the present invention;
FIG. 2 is a structural diagram of a metal operating lever according to an embodiment of the present invention;
fig. 3 is a structural diagram of the triangular balloon after the operation of penetrating the outer sleeve.
In the figure: 1. a triangular balloon; 2. a uterus oviduct liquid-through tube; 3. a liquid through port; 4. a water filling port is fixed on the saccule; 5. calibration; 6. a long rod; 7. an outer sleeve; 8. and (4) operating the head.
Detailed Description
The preferred embodiments of the present invention will be described in detail below with reference to the accompanying drawings, so that the advantages and features of the present invention can be more easily understood by those skilled in the art, and the scope of the present invention can be more clearly and clearly defined.
As shown in fig. 1, fig. 2 and fig. 3, the novel uterine cavity hemostasis, adhesion prevention and liquid perfusion composite device of the embodiment comprises a triangular balloon 1, a uterine tube liquid perfusion tube 2, a metal operating rod and an outer sleeve 7. The triangular saccule 1 is made of medical silica gel material. The surface of the triangular balloon 1 is provided with a plurality of convex fine particles. The triangular balloon 1 is hollow and has an inverted triangle shape. The bottom of the triangular saccule 1 is provided with an opening. The uterus oviduct liquid-passing tube 2 is an inverted Y-shaped tube body. The head end of the uterus oviduct liquid-passing tube 2 can be connected with the opening of the triangular saccule 1. The back two tail ends of the uterus oviduct liquid tube 2 are respectively connected with a liquid connection head 3 and a sacculus fixing head 4. The metal operating rod can penetrate through the liquid passing head 3 to reach the head of the uterus oviduct liquid passing tube 2. The two ends of the outer sleeve 7 are opened, so that the triangular balloon 1 can penetrate into and out of the outer sleeve 7. The inner diameter of the opening of the triangular balloon 1 is 3 mm. The uterus oviduct liquid tube 2 adopts a 6Fr uterus oviduct liquid tube, and the outer diameter of the uterus oviduct liquid tube 2 is 3 mm. The metal operating rod comprises an operating head 8 and a long rod 6; the operating head 8 is fixedly connected with the long rod 6. The long rod 6 has a diameter of 2 mm. The diameter of the convex fine particles was 0.3 mm. A triangular balloon 1. The uterus oviduct liquid-passing tube 2 is provided with scales 5.
The embodiment of the utility model provides a theory of operation and application method:
firstly, whether each part is complete is detected, then, the stock 6 of metal action bars passes through the liquid passing head 3 and puts into the uterus oviduct liquid passing tube 2, puts into the triangle-shaped sacculus 1 with the head end of the uterus oviduct liquid passing tube 2, makes the triangle-shaped sacculus 1 that has the uterus oviduct liquid passing tube 2 pack into the outer tube 7 in, can carry out following operation:
(1) placing into a uterine cavity: the uterine sounding is deep, the cervix can be dilated to No. 8 dilating strips, the outer sleeve 7 is arranged to be retracted by 1cm after reaching the uterine fundus, the balloon is sent into the uterine cavity by the operating rod, and the triangular balloon 1 is injected by the liquid injection head 3 after the liquid injection fixing the oviduct liquid injection tube 2.
(2) Pulling out the uterus oviduct liquid-flowing tube, and pulling out the uterus oviduct liquid-flowing tube 2 after the uterus oviduct liquid-flowing tube is left for 1 to 3 days.
(3) Taking out the triangular saccule: the triangular balloon 1 is left for the medical treatment time and then taken out.
Although the embodiments of the present invention have been described with reference to the accompanying drawings, various changes and modifications can be made by the owner within the scope of the appended claims, and the protection scope of the present invention should not be exceeded by the claims.
Claims (6)
1. The utility model provides a novel palace chamber stanchs, antiseized even, leads to liquid set composite which characterized in that: comprises a triangular sacculus, a uterus oviduct liquid-passing tube, a metal operating rod and an outer sleeve; the triangular balloon is made of an elastic silica gel material; the surface of the triangular balloon is provided with a plurality of convex fine particles; the triangular balloon is hollow and is in an inverted triangle shape; the bottom of the triangular balloon is provided with an opening; the uterus oviduct liquid-passing tube is an inverted Y-shaped tube body; the head end of the uterus oviduct liquid-passing tube can be tightly connected with the opening of the triangular saccule; the tail end of the uterus oviduct liquid-passing tube is respectively provided with a balloon fixing port and a liquid-passing port; the metal operating rod can penetrate through the liquid passing port and penetrate to the head end of the uterus oviduct liquid passing tube; the openings at the two ends of the outer sleeve enable the triangular saccule to penetrate through the inside and the outside of the outer sleeve.
2. The novel uterine cavity hemostasis, adhesion prevention and liquid circulation composite device according to claim 1 is characterized in that: the inner diameter of the opening of the triangular balloon is 3 mm; the uterus oviduct leads to the liquid pipe and adopts 6Fr uterus oviduct to lead to the liquid pipe, the pipe diameter of uterus oviduct leads to the liquid pipe is 3 mm.
3. The novel uterine cavity hemostasis, adhesion prevention and liquid circulation composite device according to claim 1 is characterized in that: the metal operating rod comprises an operating head and a long rod; the operating head is fixedly connected with a long rod; the diameter of the long rod is 2 mm.
4. The novel uterine cavity hemostasis, adhesion prevention and liquid circulation composite device according to claim 1 is characterized in that: the diameter of the outer convex fine particles was 0.3 mm.
5. The novel uterine cavity hemostasis, adhesion prevention and liquid circulation composite device according to claim 1 is characterized in that: the triangular saccule is made of medical silica gel.
6. The novel uterine cavity hemostasis, adhesion prevention and liquid circulation composite device according to claim 1 is characterized in that: scales are arranged on the uterus oviduct liquid-passing tube.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202120359574.3U CN214857300U (en) | 2021-02-06 | 2021-02-06 | Novel uterine cavity hemostasis, adhesion prevention and liquid circulation compounding device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202120359574.3U CN214857300U (en) | 2021-02-06 | 2021-02-06 | Novel uterine cavity hemostasis, adhesion prevention and liquid circulation compounding device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN214857300U true CN214857300U (en) | 2021-11-26 |
Family
ID=78858516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202120359574.3U Active CN214857300U (en) | 2021-02-06 | 2021-02-06 | Novel uterine cavity hemostasis, adhesion prevention and liquid circulation compounding device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN214857300U (en) |
-
2021
- 2021-02-06 CN CN202120359574.3U patent/CN214857300U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dhall | Amnion graft for treatment of congenital absence of the vagina | |
| CN107744417B (en) | One kind can post-operation adhesion preventing instrument in degradable uterine cavity | |
| MORTON et al. | Human amnion in the treatment of vaginal malformations | |
| EP0059218B1 (en) | Apparatus for artificial embryonation and tissue recovery | |
| NISOLLE et al. | Vaginoplasty using amniotic membranes in cases of vaginal agenesis or after vaginectomy | |
| US20030229373A1 (en) | Apparatus for preventing regeneration of endometrial synechia | |
| CN214857300U (en) | Novel uterine cavity hemostasis, adhesion prevention and liquid circulation compounding device | |
| CN108852569A (en) | A kind of degradable support diaphragm apparatus for preventing and treating Asherman's syndrom | |
| CN207118927U (en) | A kind of Medical vagina support | |
| CN207980158U (en) | A kind of disposable rodlike cervical dilator | |
| CN205626243U (en) | A birth control ware for preventing and treat adhesion of palace chamber | |
| SOLOMONS | Conception and delivery following construction of an artificial vagina: Report of a case | |
| CN205144839U (en) | Device of fang gong chamber adhesion | |
| CN106137346A (en) | A kind of degradable uterine cavity Anti-adhering device | |
| CN208710163U (en) | It is a kind of to treat pelvic organ prolapse device | |
| CN107041807B (en) | Magnetic intrauterine device | |
| CN208081646U (en) | Three chamber uterine neck balloon dilatation catheters | |
| CN217724324U (en) | Vagina expanding die | |
| CN217960258U (en) | Uterine cavity internal cutting device for treating abnormal uterine bleeding | |
| CN214226278U (en) | Lateral perineal incision model | |
| CN216169347U (en) | Anti-adhesion device for cervical orifice | |
| CN218128642U (en) | Internal pressure hemostat for postpartum care | |
| CN106618694A (en) | Medical vaginal stent | |
| CN210056185U (en) | Uterine manipulator with memory function for laparoscopic cervical cancer surgery | |
| CN110585570B (en) | Liquid-absorbing expansion self-adaptive and antibacterial dilating cervical dilator and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20220209 Address after: No.6, Shuangyong Road, Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region Patentee after: THE FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL University Address before: No.6 Shuangyong Road, Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region Patentee before: Qin Guirong |